Zacks.com on MSN15h
SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their supplemental biologics license application ...
PharmiWeb6d
Pigmented Lesion Treatment Market to Reach USD 7,6…
Pigmented Lesion Treatment MarketThe pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast ...